Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

CLL study received US FDA orphan drug development grant

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    CLL study received US FDA orphan drug development grant. Pharmacoecon. Outcomes News 489, 14 (2005). https://doi.org/10.2165/00151234-200504890-00043

    Download citation

    Keywords

    • Leukemia
    • Chronic Lymphocytic Leukaemia
    • Health Economic
    • Drug Development
    • Outcome News